Provides updates of recent ISPOR activities and events.
2018
ISPOR eBulletin (February 2018)
ISPOR eBulletin (January 2018)
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
ISPOR eBulletin Index

March 2010

The ISPOR eBULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to: www.ispor.org. Please share these new ISPOR activities with your colleagues.

 

NEW! "About ISPOR" Now Available

The “About ISPOR” booklet, a review of ISPOR’s growth and achievements, is now available in PDF format.

"About ISPOR" »

 

ANNOUNCEMENT

 

2010 ISPOR Board of Directors Election

This is a reminder to vote for the 2010-2011 ISPOR Board of Directors candidates. In this election, you have the opportunity to vote for the President-Elect (term of office 2010-2011 and as President 2011-2012) and four Directors (2010-2012). Please vote online via the ISPOR website.
ISPOR Board of Directors Election 2010 »

*Deadline to vote is: April 6, 2010.

 

MEETINGS

 

ISPOR 15th Annual International Meeting, Atlanta, GA, USA: May 15-19, 2010

**COMPLETE PROGRAM (INCLUDING 1117 CONTRIBUTED PRESENTATIONS) NOW AVAILABLE**

15th Annual International Meeting Program »

 

ISPOR 4th Asia-Pacific Conference, Phuket, Thailand:

5-7 September, 2010

*Call For Abstracts Deadline: 18 March 2010

ISPOR 4th Asia-Pacific Conference »

 

ISPOR 13th Annual European Congress, Prague, Czech Republic: 6-9 November 2010
*Call For Abstracts Deadline: 22 June 2010

For sponsorship, exhibit, advertising and symposium opportunities, see:

ISPOR 13th Annual European Congress »

 

PUBLICATIONS

 

NEW! Value in Health Early View Articles
23 Early View articles are available on-line.

Value in Health Early View articles »

NEW! Value in Health Volume 13, Issue 2 On-Line
Value in Health Volume 13, Issue 2 is now available on-line.
Value in Health Volume 13, Issue 2 »

NEW! ISPOR CONNECTIONS Volume 16, Issue 1 Now On-Line
ISPOR CONNECTIONS January/February 2010 is now available on-line. Articles include:*Thoughts on the Validity of a New QALY Estimator*Health Care Decision-Making Around the World: A Global Roadmap and Country-Specific Decision-Making and Reimbursement Processes*Assessment of Use of Pharmacoeconomics and Outcomes Research in Asia: The ISPOR Asia Consortium Needs Survey Report.

ISPOR CONNECTIONS Volume 16, Issue 1 »

 

ISPOR REGIONAL CHAPTERS/CONSORTIA

 

NEW! 9th International Symposium for Health Economics

The São Paulo Center for Health Economics hosts the 9th International Symposium for Health Economics: Sustainability of the Health Care Sector, 27-29 April 2010 in São Paulo, Brazil.  For further information visit:

ISPOR Brazil Chapter »

 

NEW! 

ISPOR SPECIAL INTEREST GROUPS/TASK FORCES

 

To join a Special Interest Group (SIG), see:

ISPOR Join Special Interest Group »

 

NEW!  ePRO Working Group
The ePRO Working Group is initiating two NEW Good Research Practices manuscript projects. The the NEW ePRO Working Group Chair is Arthur S. (Art) Zbrozek RPh, MSc, MBA, Senior Director, Health Care Relations, Field Economics Team, AstraZeneca Pharmaceuticals, Wilmington, DE, USA, and will chair the ePRO Systems Validation Manuscript Team.

The ePRO Systems Validation Subgroup »

 

The ePRO Mixed Modalities Manuscript Team will be led by  Sonya Eremenco MA, ePRO Manager, United BioSource Corporation, Bethesda, MD, USA.

Mixed Modalities Manuscript Project »

 

If you are interested in actively participating in either of these manuscript projects or would like to join the ePRO Working Group as a Review Group member, please contact: emolsen@ispor.org.

 

NEW!

ISPOR Oncology Special Interest Group (SIG)

ISPOR first disease-specific Special Interest Group was launched in February 2010 with the goal to address specific oncology outcomes research issues and to provide a forum for oncology researchers as well as oncology clinicians to promote the sharing of knowledge about oncology outcomes research. The ISPOR Oncology Outcomes Research Working Group was formed under the umbrella of the Oncology SIG, with the following objectives:

* Identify specific clinical information that outcomes researchers need to know in order to conduct good oncology outcomes research.

* Develop a repository of different oncology resources on the ISPOR website including links to related websites, guidelines, and articles that provide the necessary knowledge to help enhance the quality of oncology outcomes research.

 

For more information, see: ISPOR Oncology Outcomes Research Working Group. To join this Working Group, see: ISPOR Join Special Interest Group »

 

 

***************** Advertisements**************

LSE Logo

MSc in Health Economics Policy and Management

 

Founded in 1895, the London School of Economics and Political Science is now the world’s leading dedicated social science institution. The School is offering healthcare, pharmaceutical and public sector professionals a unique opportunity to work full time and gain formal qualifications at the same time in topics such as:

 

health management and administration ● health economics cost-effectiveness and statistical analysis ● health policy ● pharmaceutical economics ● epidemiology/clinical trials ● health information systems

 

This modular MSc programme is operated by LSE Health
(
http://www2.lse.ac.uk/LSEHealthAndSocialCare/LSEHealth/Home.aspx) and the Department of Social Policy
(
http://www2.lse.ac.uk/socialPolicy/Home.aspx) at the London School of Economics and Political Science.

 

Additional teaching is provided by the Department of Management and the European Institute as well as subject experts from other UK academic institutions. 

 

The programme starts in December 2010.  The MSc will take two years to complete with two intensive sessions each academic year - December 2010, June 2011, December 2011 and June 2012.  The MSc will require a total of 41 days in London for teaching and examinations over two years with extensive off-site support in-between.

 

Diploma and certificate options are also available. For additional information please contact:

HEPM@lse.ac.uk

 

ccpe logo_web

Measurement, Design, and Analysis Methods for Health Outcomes Research

 

Learn research in the newly funded area of comparative effectiveness studies.

 

Register Today! Visit: www.hsph.harvard.edu/ccpe/MDA or call: 617-384-8692

 

Taught in an interactive classroom setting, this program is geared towards introductory to intermediate learning levels to help participants design, implement, and analyze outcomes studies, and critically review and use outcomes data for clinical decision making, health care planning, and technology development. The program provides participants with an overview of several topics in the newly funded field of comparative effectiveness studies, equipping newcomers with knowledge of the language and concepts.

"The U.S. spends more than $2 trillion a year on health care, but we have little information about which treatments work best for which patients." — Representative Pete Stark, Democrat of California

Chairman of the Ways and Means Subcommittee on   Health

 

The economic stimulus bill approved by Congress, for the first time, provides substantial amounts of money to compare the effectiveness of different treatments for the same illness, responding to a growing concern that doctors have little or no solid evidence of the value of many treatments.

 

In an increasingly competitive health care market, outcomes evaluation and research is important for:

 

Improving patient outcomes ● Controlling costs and allocating resources ● Implementing disease management programs ● Making effective clinical and business decisions ● Developing and marketing health care products and services ● Saving money by discouraging the use of costly, ineffective treatments

 

Improving your analytical and quantitative skills will greatly enhance the use of health outcomes research at your organization.

 

"This is an excellent program, covering a wide range of health economic and outcomes related topics, and taught by an expert faculty. Great for those wanting to gain or improve their knowledge in outcomes research and underlying methods."— Steven Blum, Associate Director, Health Economics, Forest Research Institute, Jersey City, NJ, USA.

 

CME and CEU Credits Available. For a detailed agenda or to register, visit: www.hsph.harvard.edu/ccpe/MDA or call: 617-384-8692.  Please be sure to mention your Reference Code:  MDA10-IP01 in all correspondence.

 

This program is recognized by the Society for Risk Analysis.

 

*******************************************

 

TIP OF THE MONTH- ISPOR Website Site Map
The Site Map on the ISPOR homepage gives you a quick and comprehensive look at the ISPOR website and provides over 20 ISPOR areas of interests and links to many useful resources. To access the ISPOR Site Map, simply click the Site Map Link on the ISPOR website homepage.


This newsletter is provided as a benefit of membership in ISPOR. If you received this from a colleague and are not a current ISPOR member, please consider becoming an individual member or organizational affiliate.  Contact membership services for more information and its use in health care decisions.

 

The International Society for Pharmacoeconomics and Outcomes Research is an international organization promoting the science of pharmacoeconomics and health outcomes research.


3100 Princeton Pike, Suite 3E, Lawrenceville, NJ, 08648 USA

Tel: 609-219-0773 Toll Free: 1-800-992-0643 Fax: 609-219-0774

 

IMPORTANT
DATES TO REMEMBER

 

18 March 2010

ISPOR 4th Asia-Pacific Conference Abstract Deadline
More »

May 15-19, 2010
ISPOR 15th Annual International Meeting
More »

5-7 September 2010
ISPOR 4th Asia-Pacific Conference
More »

 

QUICK LINKS

Value in Health

 

ISPOR CONNECTIONS

 

ISPOR Research Digest

 

ISPOR Book of Terms

 

ISPOR Good Research Practices

 

Special Interest Groups (SIGs)

 

ISPOR Student Network

 

ISPOR Regional Chapters

 

ISPOR Latin America Consortium

 

ISPOR Asia Consortium

 

Membership

 

Employment